What is CaNCURE?

CaNCURE was created to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Over 50 trainees have already completed the program.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research lab.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
 Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

66

Trainees

33

Mentors

22

Publications

108

Presentations


Hear from our Alumni:

“The work that I am doing may one day assist in providing new ways of identifying and monitoring cancer.  This means that physicians could find cancer earlier and provide patients with better treatment options, tailored to their individual disease at that moment in time.  This would improve patient’s prognosis and quality of life, which is the most important thing in the world.”

Rachel Fontana, Biochemistry, ’16


Trainee Spotlight


Adrienne Orriols

Behavioral Neuroscience, '19

Characterization of Nano-Dinaciclib in Combination with Nano-Talazoparib for the Treatment of Breast Cancer

Mostafa Abdelhalim

Biochemistry, '21

Targeted Delivery of Liposomes using PARP Inhibitors to Treat Non-Small Cell Lung Cancer

Nidhi Shankar

Health Science, '19

Molecular Analysis of Plasma Vesicles for Early Pancreatic Cancer Detection

Featured Trainee Publication


Upcoming Events

Introducing Photomedics, Inc.

Friday, January 18, 2019

Nikos Soukos, DDS, Ph.D., Founder & CEO, Photomedics, Inc.

119 Snell Libary -- NEU, 3:25 PM


Mentor Spotlight


Anna Moore, Ph.D.

Professor of Radiology, HMS

Our research deals with non-invasive imaging of molecular targets in cancer. Students with have the opportunity to explore the use of targeted multimodal nanoparticles for imaging of tumor growth, metastasis, and treatment.


Michail Sitkovsky, Ph.D.

Professor and Chair of Immunophysiology and Pharmaceutical Biotechnology, NEU

A nanotechnology-based approach has been developed by this group to deliver co-adjuvants in a novel immunotherapy of cancer. Students will study how anti-tumor CD8 T-cells, modified with polymeric nanoparticles containing the A2A receptor antagonist and/or T cell-activating cytokine, increase local concentration of drugs in the tumor micro-environment.


Trainee Spotlight


Rreze Grajcevci

Health Sciences, '21

Analyzing metastasis through targeted miRNA nanotherapy in aggressive breast cancer

Mostafa Abdelhalim

Biochemistry, '21

Targeted Delivery of Liposomes using PARP Inhibitors to Treat Non-Small Cell Lung Cancer

Daem Celestin

Cell and Molecular Biology, '21

The Nano-plasmonic Exosome (nPLEX) Assay for Pancreatic Ductal Adenocarcinoma Diagnosis and Prognosis


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...